227 related articles for article (PubMed ID: 33973154)
21. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
22. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy.
Apple AC; Schroeder MP; Ryals AJ; Wagner LI; Cella D; Shih PA; Reilly J; Penedo FJ; Voss JL; Wang L
Neuroimage Clin; 2018; 20():110-118. PubMed ID: 30094161
[TBL] [Abstract][Full Text] [Related]
24. Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables.
Yang Y; Hendrix CC
Asia Pac J Oncol Nurs; 2018; 5(3):296-306. PubMed ID: 29963592
[TBL] [Abstract][Full Text] [Related]
25. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
[TBL] [Abstract][Full Text] [Related]
26. Comparative Analysis of the Chemotherapy-Related Cognitive Impairments in Patients with Breast Cancer: A Community-Based Research.
Owrangi M; Gholamzadeh MJ; Vasaghi Gharamaleki M; Mousavi SZ; Kamali AM; Dehghani M; Chakrabarti P; Nami M
Cancer Invest; 2022 Oct; 40(9):811-821. PubMed ID: 35880822
[TBL] [Abstract][Full Text] [Related]
27. Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review.
Tyagi K; Masoom M; Majid H; Garg A; Bhurani D; Agarwal NB; Khan MA
Curr Rev Clin Exp Pharmacol; 2023; 18(2):110-119. PubMed ID: 35249524
[TBL] [Abstract][Full Text] [Related]
28. Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.
Vega JN; Dumas J; Newhouse PA
Am J Geriatr Psychiatry; 2017 Dec; 25(12):1415-1426. PubMed ID: 28495470
[TBL] [Abstract][Full Text] [Related]
29. Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol.
Gokal K; Munir F; Wallis D; Ahmed S; Boiangiu I; Kancherla K
BMC Public Health; 2015 Apr; 15():414. PubMed ID: 25903195
[TBL] [Abstract][Full Text] [Related]
30. Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review.
Jia M; Zhang X; Wei L; Gao J
Asia Pac J Clin Oncol; 2021 Aug; 17(4):321-329. PubMed ID: 33079484
[TBL] [Abstract][Full Text] [Related]
31. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
32. A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON).
Tack L; Lefebvre T; Lycke M; Langenaeken C; Fontaine C; Borms M; Hanssens M; Knops C; Meryck K; Boterberg T; Pottel H; Schofield P; Debruyne PR
EClinicalMedicine; 2021 Sep; 39():101081. PubMed ID: 34466793
[TBL] [Abstract][Full Text] [Related]
33. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
Dos Santos M; Hardy-Léger I; Rigal O; Licaj I; Dauchy S; Levy C; Noal S; Segura C; Delcambre C; Allouache D; Parzy A; Barriere J; Petit T; Lange M; Capel A; Clarisse B; Grellard JM; Lefel J; Joly F
Cancer; 2020 Dec; 126(24):5328-5336. PubMed ID: 32996583
[TBL] [Abstract][Full Text] [Related]
34. The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.
Whitford HS; Kalinowski P; Schembri A; Grimison P; Stockler M; Martin A; Toner GC; Davis ID; Maruff P; Olver IN;
Support Care Cancer; 2020 Jul; 28(7):3081-3091. PubMed ID: 31642990
[TBL] [Abstract][Full Text] [Related]
35. Biological and psychological predictors of cognitive function in breast cancer patients before surgery.
Aspelund SG; Halldorsdottir T; Agustsson G; Sigurdardottir Tobin HR; Wu LM; Amidi A; Johannsdottir KR; Lutgendorf SK; Telles R; Daly HF; Sigurdardottir K; Valdimarsdottir HB; Baldursdottir B
Support Care Cancer; 2024 Jan; 32(1):88. PubMed ID: 38185720
[TBL] [Abstract][Full Text] [Related]
36. An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
Oppegaard KR; Mayo SJ; Armstrong TS; Kober KM; Anguera JA; Wright F; Levine JD; Conley YP; Paul S; Cooper B; Miaskowski C
Nurs Res; 2023 Jul-Aug 01; 72(4):272-280. PubMed ID: 37104681
[TBL] [Abstract][Full Text] [Related]
37. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
38. Loneliness as a risk factor for cancer-related cognitive impairment: a secondary data analysis from the Haze study.
Sleight AG; Myers JS; Cook-Wiens G; Baynes R; Jo MY; Asher A
Disabil Rehabil; 2023 Jul; 45(14):2325-2328. PubMed ID: 35760769
[TBL] [Abstract][Full Text] [Related]
39. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
40. A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial.
Van der Gucht K; Melis M; Ahmadoun S; Gebruers A; Smeets A; Vandenbulcke M; Wildiers H; Neven P; Kuppens P; Raes F; Sunaert S; Deprez S
Trials; 2020 Mar; 21(1):290. PubMed ID: 32293533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
